{"id":268,"date":"2026-11-04T17:29:05","date_gmt":"2026-11-04T17:29:05","guid":{"rendered":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/"},"modified":"2026-11-06T16:27:17","modified_gmt":"2026-11-06T16:27:17","slug":"modafinil-adhd-off-label","status":"publish","type":"post","link":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/","title":{"rendered":"Modafinil and ADHD: why it isn&#8217;t licensed, MS fatigue and other off-label uses"},"content":{"rendered":"<div class=\"ym-article\">\n<p class=\"ym-answer\">Modafinil and ADHD: in the UK, modafinil is not licensed to treat ADHD. Its only licensed use is excessive sleepiness caused by narcolepsy in adults, and it should not be used in anyone under 18. If you have ADHD, an ADHD specialist can talk you through the licensed medicines and other support that NICE recommends.<\/p>\n<div class=\"ym-facts\">\n<h2>Key facts<\/h2>\n<ul>\n<li><strong>What it is:<\/strong> A wakefulness-promoting medicine.<\/li>\n<li><strong>Licensed use (UK):<\/strong> Excessive sleepiness associated with narcolepsy, with or without cataplexy, in adults.<\/li>\n<li><strong>Legal status:<\/strong> Prescription-only medicine (POM).<\/li>\n<li><strong>Needs a prescription:<\/strong> Yes<\/li>\n<li><strong>Last checked:<\/strong> November 2026<\/li>\n<\/ul>\n<\/div>\n<p>Many people read about modafinil as a possible ADHD treatment, often on US websites. This guide explains what UK regulators, NICE and the research actually say. It also covers fatigue in multiple sclerosis (MS) and other uses outside the licence. For an overview of the medicine, see our <a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil\/\">complete guide to modafinil<\/a>.<\/p>\n<h2 id=\"licence\">Is modafinil licensed for ADHD in the UK?<\/h2>\n<p>No. The <a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/4319\/smpc\">UK Summary of Product Characteristics (SmPC) for modafinil<\/a> lists one licensed use. That is excessive sleepiness associated with narcolepsy, with or without cataplexy, in adults.<\/p>\n<p>The SmPC also says modafinil should only be used after a full assessment of your sleepiness. A diagnosis of narcolepsy should be made using recognised diagnostic criteria. ADHD is not part of the licence.<\/p>\n<p>Using a medicine outside its licence is called &#8220;off-label&#8221; use. It means the regulator has not judged the medicine safe and effective for that purpose. Some specialists do prescribe off-label in specific situations, but they take extra responsibility for that decision.<\/p>\n<h2 id=\"restricted\">Why modafinil is restricted to narcolepsy<\/h2>\n<p>Modafinil used to be licensed for more sleep conditions. In 2010 the European Medicines Agency (EMA) reviewed its benefits and risks. The <a href=\"https:\/\/ema.europa.eu\/en\/documents\/press-release\/european-medicines-agency-recommends-restricting-use-modafinil_en.pdf\">EMA press release of 22 July 2010<\/a> said the review began because of safety concerns. These were psychiatric disorders, skin reactions, significant off-label use and potential for abuse.<\/p>\n<p>The EMA concluded that the benefits only outweighed the risks in narcolepsy. For other uses, it found that the risk of skin, hypersensitivity and neuropsychiatric reactions outweighed the evidence of benefit. Doctors were told to stop using it for idiopathic hypersomnia, sleepiness linked to obstructive sleep apnoea and shift work sleep disorder.<\/p>\n<p>The <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/modafinil\">EMA referral record<\/a> notes that modafinil had often been used for conditions it was not indicated for. In the UK, the <a href=\"https:\/\/www.gov.uk\/drug-safety-update\/modafinil-provigil-now-restricted-to-narcolepsy\">MHRA Drug Safety Update of March 2011<\/a> told prescribers that modafinil is now restricted to narcolepsy.<\/p>\n<h3 id=\"children\">Why modafinil must not be used in children<\/h3>\n<p>ADHD is often diagnosed in childhood, so this point matters. The SmPC says modafinil should not be used in children under 18 because of safety and efficacy concerns.<\/p>\n<p>The main worry is serious skin reactions. In clinical trials, about 0.8% of children and young people under 17 (13 out of 1,585) stopped modafinil because of a rash, including serious rash. No serious skin rashes were reported in adult trials (0 out of 4,264).<\/p>\n<p>The EMA said the risk of serious skin and hypersensitivity reactions appears higher in children than in adults. It recommended that modafinil should not be prescribed to children.<\/p>\n<h2 id=\"evidence\">What the evidence says about modafinil for adult ADHD<\/h2>\n<p>Studies of modafinil in adults with ADHD have been disappointing. A <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30117329\/\">2019 systematic review and meta-analysis in the Annals of Pharmacotherapy<\/a> pooled randomised, placebo-controlled trials in adults with ADHD.<\/p>\n<p>It compared lisdexamfetamine, mixed amphetamine salts, methylphenidate and modafinil. The authors found no efficacy for modafinil compared with placebo. Lisdexamfetamine had the largest effect.<\/p>\n<p>So &#8220;modafinil for ADHD in adults&#8221; is not supported by good evidence. Online stories about it working well are personal reports, not proof. They also miss the safety checks that a specialist would carry out.<\/p>\n<h2 id=\"nice-adhd\">What NICE and the NHS recommend for ADHD<\/h2>\n<p>The <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng87\/resources\/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933\">NICE guideline on ADHD (NG87)<\/a> sets out how ADHD should be diagnosed and treated in England. It says ADHD should only be diagnosed by a specialist with training and expertise in ADHD. Medicines for ADHD should only be started by a healthcare professional with that same expertise.<\/p>\n<p>For adults, NICE names lisdexamfetamine or methylphenidate as first-line medicine options. Other options, such as atomoxetine, are for people who cannot take or do not respond to these. For children aged 5 and over, methylphenidate is the usual first choice, with other medicines as later options. Modafinil does not appear in the guideline.<\/p>\n<p>The <a href=\"https:\/\/www.nhs.uk\/conditions\/adhd-adults\/\">NHS page on ADHD in adults<\/a> says medicines that can help include methylphenidate or lisdexamfetamine. It says ADHD medicines must be started and monitored by an ADHD specialist. A GP may take over prescribing only under a &#8220;shared care agreement&#8221; with that specialist.<\/p>\n<p>Medicine is not the only option. The NHS says talking therapies, such as cognitive behavioural therapy (CBT) or mindfulness, may be recommended for adults. The <a href=\"https:\/\/www.nhs.uk\/conditions\/adhd-children-teenagers\/\">NHS page on ADHD in children and young people<\/a> adds that not everyone with ADHD needs or wants to take medicine.<\/p>\n<h2 id=\"comparison\">Modafinil vs Adderall and Ritalin<\/h2>\n<p>Ritalin is a brand name for methylphenidate. Adderall is a US brand of mixed amphetamine salts. Here is how they compare on the points that matter in the UK.<\/p>\n<table>\n<thead>\n<tr>\n<th><\/th>\n<th>Modafinil<\/th>\n<th>Methylphenidate (for example, Ritalin)<\/th>\n<th>Adderall (mixed amphetamine salts)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Licensed UK use<\/td>\n<td>Sleepiness from narcolepsy in adults only<\/td>\n<td>Named by NICE and the NHS as an ADHD medicine<\/td>\n<td>Not named in the NICE or NHS ADHD guidance we checked<\/td>\n<\/tr>\n<tr>\n<td>Named in NICE ADHD guideline (NG87)<\/td>\n<td>No<\/td>\n<td>Yes, first line for children 5+ and one of two first-line options for adults<\/td>\n<td>No<\/td>\n<\/tr>\n<tr>\n<td>Adult ADHD trials (2019 meta-analysis)<\/td>\n<td>No efficacy shown compared with placebo<\/td>\n<td>Moderate effect compared with placebo<\/td>\n<td>Moderate effect compared with placebo<\/td>\n<\/tr>\n<tr>\n<td>Use in under-18s<\/td>\n<td>Should not be used<\/td>\n<td>Specialist decision under NICE guidance<\/td>\n<td>Not applicable in UK guidance<\/td>\n<\/tr>\n<tr>\n<td>Who starts it<\/td>\n<td>Specialist, after full sleep assessment<\/td>\n<td>ADHD specialist<\/td>\n<td>Not applicable in UK guidance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The table shows why the comparison is not like-for-like. Modafinil is a narcolepsy medicine, and the others are ADHD treatments with their own risks. Never swap one for another without your specialist.<\/p>\n<h2 id=\"ms\">Modafinil for MS fatigue<\/h2>\n<p>Fatigue is one of the most common symptoms of multiple sclerosis. The <a href=\"https:\/\/www.nhs.uk\/conditions\/multiple-sclerosis\/treatment\/\">NHS page on MS treatment<\/a> describes support such as advice on managing tiredness and CBT to help with fatigue.<\/p>\n<p>The <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng220\/resources\/multiple-sclerosis-in-adults-management-pdf-66143828948677\">NICE guideline on MS in adults (NG220)<\/a>, published in June 2022, does mention modafinil. If a person with MS wants to try a medicine for fatigue, NICE says they should be referred to a specialist to discuss the options. Using shared decision making, the specialist may consider amantadine, modafinil or an SSRI antidepressant.<\/p>\n<p>NICE notes that modafinil should not be used by people who are pregnant or planning a pregnancy. It also states that in June 2022 this was an off-label use of all three medicines. The <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng220\">NG220 guideline page<\/a> confirms it replaced NICE&#8217;s earlier evidence summary on modafinil for MS fatigue.<\/p>\n<p>So &#8220;modafinil for MS&#8221; is a specialist decision, not a routine treatment. Your MS team will weigh it against the warnings in the SmPC. They will also help with non-drug approaches first.<\/p>\n<h2 id=\"other\">Other off-label uses and why caution matters<\/h2>\n<p>Since the 2010 review, the EMA says modafinil should no longer be used for:<\/p>\n<ul>\n<li>obstructive sleep apnoea<\/li>\n<li>shift work sleep disorder<\/li>\n<li>idiopathic hypersomnia<\/li>\n<\/ul>\n<p>Some people also take modafinil to stay alert or study, without a medical need. The EMA noted reports of use for &#8220;performance enhancement&#8221; and asked for this to be monitored. Our guide on <a href=\"https:\/\/yourmedsuk.com\/insights\/is-modafinil-addictive\/\">whether modafinil is addictive<\/a> explains the dependence warnings.<\/p>\n<p>Modafinil is a prescription-only medicine in the UK. Our <a href=\"https:\/\/yourmedsuk.com\/insights\/is-modafinil-legal-uk\/\">guide to modafinil and UK law<\/a> explains what that means.<\/p>\n<h2 id=\"safety\">Safety checks your prescriber will make<\/h2>\n<p>Whatever the reason for prescribing, the SmPC sets out checks. We do not give doses for off-label uses. If you are prescribed modafinil, take it exactly as your prescriber tells you.<\/p>\n<ul>\n<li><strong>Heart:<\/strong> an ECG is recommended before starting. Blood pressure and heart rate should be checked regularly. See <a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-heart-blood-pressure\/\">modafinil, your heart and blood pressure<\/a>.<\/li>\n<li><strong>Mental health:<\/strong> you should be monitored for new or worsening psychiatric symptoms at every dose change and during treatment.<\/li>\n<li><strong>Skin:<\/strong> modafinil should be stopped at the first sign of rash and not restarted.<\/li>\n<li><strong>Pregnancy:<\/strong> the MHRA says modafinil should not be used in pregnancy. If you could become pregnant, use effective contraception during treatment and for 2 months after stopping. Read <a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-pregnancy-contraception\/\">modafinil, pregnancy and contraception<\/a>.<\/li>\n<li><strong>Other medicines:<\/strong> modafinil can interact with other medicines. See <a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-interactions\/\">modafinil interactions<\/a>.<\/li>\n<\/ul>\n<div class=\"ym-help\">\n<h2>When to get help<\/h2>\n<p><strong>Call 999 or go to A&amp;E<\/strong> if you take modafinil and have:<\/p>\n<ul>\n<li>a rash with blistering, peeling skin or sores in your mouth, eyes or genitals<\/li>\n<li>swelling of your face, lips, tongue or throat, or trouble breathing<\/li>\n<li>chest pain or a fast, irregular heartbeat<\/li>\n<li>thoughts of harming yourself or ending your life<\/li>\n<\/ul>\n<p><strong>Contact your prescriber or call NHS 111<\/strong> if you get any rash, new anxiety, low mood or changes in behaviour, or if you think your ADHD or fatigue treatment is not working.<\/p>\n<p>You can report suspected side effects to the MHRA through the <a href=\"https:\/\/yellowcard.mhra.gov.uk\/\">Yellow Card scheme<\/a>.<\/p>\n<\/div>\n<div class=\"ym-faq\">\n<h2>Frequently asked questions<\/h2>\n<h3>Can modafinil be prescribed for ADHD in the UK?<\/h3>\n<p>Modafinil is not licensed for ADHD in the UK, and NICE&#8217;s ADHD guideline does not include it. The licensed ADHD medicines are started by an ADHD specialist. Ask your GP about a referral if you think you have ADHD.<\/p>\n<h3>Why is modafinil not approved for ADHD?<\/h3>\n<p>Trials in adults have not shown a clear benefit over placebo. In children, the risk of serious skin reactions is a major concern. The EMA found its benefits only outweigh its risks in narcolepsy.<\/p>\n<h3>Modafinil vs Ritalin: which is better for ADHD?<\/h3>\n<p>Ritalin is a brand of methylphenidate, which NICE names as an ADHD medicine. Modafinil is a narcolepsy medicine with no shown benefit in adult ADHD trials. Your specialist will choose a treatment based on your needs and health.<\/p>\n<h3>Modafinil vs Adderall: what is the difference?<\/h3>\n<p>Adderall is a US brand of mixed amphetamine salts used for ADHD there. Modafinil is licensed in the UK only for sleepiness caused by narcolepsy. Neither should be taken unless a prescriber has advised it for you.<\/p>\n<h3>Is modafinil used for MS fatigue?<\/h3>\n<p>Sometimes, by specialists. NICE says an MS specialist may consider amantadine, modafinil or an SSRI for fatigue after a full discussion. NICE notes this is off-label use and modafinil is not for people who are pregnant or planning pregnancy.<\/p>\n<h3>Can children take modafinil?<\/h3>\n<p>No. The UK product information says modafinil should not be used in anyone under 18. This is because of safety and efficacy concerns, including serious skin reactions.<\/p>\n<\/div>\n<div class=\"ym-related\">\n<h2>Related guides<\/h2>\n<ul>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil\/\">Modafinil: what it is, how it works and who it\u2019s for<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-side-effects\/\">Modafinil side effects: common, serious and when to get help<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/is-modafinil-addictive\/\">Is modafinil addictive? Dependence, withdrawal and stopping safely<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-heart-blood-pressure\/\">Is modafinil safe? Your heart, blood pressure and long-term use<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/is-modafinil-legal-uk\/\">Modafinil in the UK: is it legal and is it a controlled drug?<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/narcolepsy\/\">Narcolepsy and excessive sleepiness<\/a><\/li>\n<li><a href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-smart-drug\/\">Modafinil benefits: does the &#8216;smart drug&#8217; work, and what are the risks?<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"ym-refs\">\n<h2>References<\/h2>\n<ol>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/4319\/smpc\">Modafinil 100 mg tablets \u2013 Summary of Product Characteristics<\/a>, electronic medicines compendium (emc), accessed November 2026<\/li>\n<li><a href=\"https:\/\/ema.europa.eu\/en\/documents\/press-release\/european-medicines-agency-recommends-restricting-use-modafinil_en.pdf\">European Medicines Agency recommends restricting the use of modafinil<\/a>, European Medicines Agency, 22 July 2010, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/modafinil\">Modafinil \u2013 referral<\/a>, European Medicines Agency, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.gov.uk\/drug-safety-update\/modafinil-provigil-now-restricted-to-narcolepsy\">Modafinil (Provigil): now restricted to narcolepsy<\/a>, MHRA Drug Safety Update, March 2011, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng87\/resources\/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933\">Attention deficit hyperactivity disorder: diagnosis and management (NG87)<\/a>, NICE, published March 2018, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng220\/resources\/multiple-sclerosis-in-adults-management-pdf-66143828948677\">Multiple sclerosis in adults: management (NG220)<\/a>, NICE, June 2022, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng220\">NG220 overview<\/a>, NICE, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nhs.uk\/conditions\/adhd-adults\/\">ADHD in adults<\/a>, NHS, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nhs.uk\/conditions\/adhd-children-teenagers\/\">ADHD in children and young people<\/a>, NHS, accessed November 2026<\/li>\n<li><a href=\"https:\/\/www.nhs.uk\/conditions\/multiple-sclerosis\/treatment\/\">Multiple sclerosis: treatment<\/a>, NHS, accessed November 2026<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30117329\/\">Efficacy, acceptability, and tolerability of lisdexamfetamine, mixed amphetamine salts, methylphenidate, and modafinil in the treatment of ADHD in adults: a systematic review and meta-analysis<\/a>, Annals of Pharmacotherapy, 2019;53(2):121-133, accessed November 2026<\/li>\n<\/ol>\n<\/div>\n<p class=\"ym-disclaimer\">This article is for information only and does not replace advice from your doctor or pharmacist. Read our <a href=\"https:\/\/yourmedsuk.com\/insights\/medical-disclaimer\/\">medical disclaimer<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Modafinil and ADHD explained for UK readers: why modafinil isn&#8217;t licensed for ADHD, what the evidence and the EMA review found, what NICE recommends instead, how it compares with Ritalin and Adderall, and when specialists consider it for MS fatigue.<\/p>\n","protected":false},"author":1,"featured_media":267,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-modafinil"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK<\/title>\n<meta name=\"description\" content=\"Modafinil and ADHD: why it isn&#039;t licensed in the UK, what the evidence shows, NICE&#039;s recommended options, Ritalin and Adderall compared, and MS fatigue.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK\" \/>\n<meta property=\"og:description\" content=\"Modafinil and ADHD: why it isn&#039;t licensed in the UK, what the evidence shows, NICE&#039;s recommended options, Ritalin and Adderall compared, and MS fatigue.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/\" \/>\n<meta property=\"og:site_name\" content=\"Your Meds UK Insights\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-04T17:29:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-06T16:27:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/#\\\/schema\\\/person\\\/2d22a97e52cdd22e45f66f843992c8ad\"},\"headline\":\"Modafinil and ADHD: why it isn&#8217;t licensed, MS fatigue and other off-label uses\",\"datePublished\":\"2026-11-04T17:29:05+00:00\",\"dateModified\":\"2026-11-06T16:27:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/\"},\"wordCount\":1953,\"image\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/11\\\/modafinil-adhd-off-label-featured.jpg\",\"articleSection\":[\"Modafinil\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/\",\"url\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/\",\"name\":\"Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/11\\\/modafinil-adhd-off-label-featured.jpg\",\"datePublished\":\"2026-11-04T17:29:05+00:00\",\"dateModified\":\"2026-11-06T16:27:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/#\\\/schema\\\/person\\\/2d22a97e52cdd22e45f66f843992c8ad\"},\"description\":\"Modafinil and ADHD: why it isn't licensed in the UK, what the evidence shows, NICE's recommended options, Ritalin and Adderall compared, and MS fatigue.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#primaryimage\",\"url\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/11\\\/modafinil-adhd-off-label-featured.jpg\",\"contentUrl\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/11\\\/modafinil-adhd-off-label-featured.jpg\",\"width\":1600,\"height\":900,\"caption\":\"Illustration of a study desk by a window with books, a lamp and a compass on a notebook\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/modafinil-adhd-off-label\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Modafinil and ADHD: why it isn&#8217;t licensed, MS fatigue and other off-label uses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/\",\"name\":\"Your Meds UK Insights\",\"description\":\"Clear, evidence-based information about prescription medicines\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/yourmedsuk.com\\\/insights\\\/#\\\/schema\\\/person\\\/2d22a97e52cdd22e45f66f843992c8ad\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/yourmedsuk.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK","description":"Modafinil and ADHD: why it isn't licensed in the UK, what the evidence shows, NICE's recommended options, Ritalin and Adderall compared, and MS fatigue.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/","og_locale":"en_US","og_type":"article","og_title":"Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK","og_description":"Modafinil and ADHD: why it isn't licensed in the UK, what the evidence shows, NICE's recommended options, Ritalin and Adderall compared, and MS fatigue.","og_url":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/","og_site_name":"Your Meds UK Insights","article_published_time":"2026-11-04T17:29:05+00:00","article_modified_time":"2026-11-06T16:27:17+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#article","isPartOf":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/"},"author":{"name":"admin","@id":"https:\/\/yourmedsuk.com\/insights\/#\/schema\/person\/2d22a97e52cdd22e45f66f843992c8ad"},"headline":"Modafinil and ADHD: why it isn&#8217;t licensed, MS fatigue and other off-label uses","datePublished":"2026-11-04T17:29:05+00:00","dateModified":"2026-11-06T16:27:17+00:00","mainEntityOfPage":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/"},"wordCount":1953,"image":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#primaryimage"},"thumbnailUrl":"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg","articleSection":["Modafinil"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/","url":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/","name":"Modafinil and ADHD: Is It Licensed in the UK? | Your Meds UK","isPartOf":{"@id":"https:\/\/yourmedsuk.com\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#primaryimage"},"image":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#primaryimage"},"thumbnailUrl":"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg","datePublished":"2026-11-04T17:29:05+00:00","dateModified":"2026-11-06T16:27:17+00:00","author":{"@id":"https:\/\/yourmedsuk.com\/insights\/#\/schema\/person\/2d22a97e52cdd22e45f66f843992c8ad"},"description":"Modafinil and ADHD: why it isn't licensed in the UK, what the evidence shows, NICE's recommended options, Ritalin and Adderall compared, and MS fatigue.","breadcrumb":{"@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#primaryimage","url":"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg","contentUrl":"https:\/\/yourmedsuk.com\/insights\/wp-content\/uploads\/sites\/2\/2026\/11\/modafinil-adhd-off-label-featured.jpg","width":1600,"height":900,"caption":"Illustration of a study desk by a window with books, a lamp and a compass on a notebook"},{"@type":"BreadcrumbList","@id":"https:\/\/yourmedsuk.com\/insights\/modafinil-adhd-off-label\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/yourmedsuk.com\/insights\/"},{"@type":"ListItem","position":2,"name":"Modafinil and ADHD: why it isn&#8217;t licensed, MS fatigue and other off-label uses"}]},{"@type":"WebSite","@id":"https:\/\/yourmedsuk.com\/insights\/#website","url":"https:\/\/yourmedsuk.com\/insights\/","name":"Your Meds UK Insights","description":"Clear, evidence-based information about prescription medicines","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/yourmedsuk.com\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/yourmedsuk.com\/insights\/#\/schema\/person\/2d22a97e52cdd22e45f66f843992c8ad","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d5aa49fb4903804dad411af42f9931fc2220159a1df3a9eb58a22fd6000401dc?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/yourmedsuk.com"]}]}},"_links":{"self":[{"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/posts\/268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/comments?post=268"}],"version-history":[{"count":2,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/posts\/268\/revisions"}],"predecessor-version":[{"id":293,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/posts\/268\/revisions\/293"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/media\/267"}],"wp:attachment":[{"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/media?parent=268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/categories?post=268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/yourmedsuk.com\/insights\/wp-json\/wp\/v2\/tags?post=268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}